Key facts
- Hinge Health (NYS: HNGE)’s last known valuation is $2.6B (May 2025).
- It has raised $1.1B; the latest was IPO ($502.9M) in May 2025.
- Notable investors include Insight Partners (New York), Bessemer Venture Partners, Tiger Global Management, Lead Edge Capital, Coatue Management — 8 tracked in total.
- 3 institutional filers report fund marks on Hinge Health (NYS: HNGE) across 9 filings.
- Status: Publicly Held.
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for Hinge Health (NYS: HNGE)
- ·The full record, as it builds
Funding rounds
No funding rounds for Hinge Health (NYS: HNGE) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Hinge Health (NYS: HNGE)
Hinge Health Inc is a technology platform for individuals seeking to treat and prevent joint and muscle pain. Through a combination of AI-powered motion tracking technology, the Company's platform helps members address chronic musculoskeletal (MSK) conditions, enables improved member outcomes and supports cost reductions for its clients.
- Sector
- Healthcare
- HQ
- San Francisco, CA, United States
- Founded
- 2014
- Employees
- 1,437
- Website
- hingehealth.com/
- Ownership
- Publicly Held
Hinge Health (NYS: HNGE) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Hinge Health (NYS: HNGE) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
3 filers · latest May 20263 SEC-registered funds reported 9 fair-value marks on Hinge Health (NYS: HNGE) between May 2025 and May 2026. Filer-level marks and implied $/share are available to Pro members.